Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra
Status:
Unknown status
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
Open label pharmacokinetic RBT dose-finding study in young (≤ 5 year old) HIV-infected
children receiving a LPV/RTV-based ART regimen and who have a recent history of completing TB
treatment.